Company intelligence / Profile preview

SOFAR

Trezzano Rosa, Lombardia, Italysofarsolar.com ↗
Ownership
Private
Employees
~300
Development stage
Commercial
01

Overview

SOFAR has a long-standing commercial presence with over 150 marketed products in more than 10 therapeutic areas. Its portfolio is especially strong in gastrointestinal health and probiotics/microbiota research. The company’s leading brands include Pentacol (for IBD), Enterolactis (probiotic), Gerdoff (gastroesophageal reflux), Cistiflux and Siler (gynecology/urology). Clinical results are not typically published for supplements/devices but the company is recognized for high-quality standards and innovation[1][2][3][6].

Therapeutic areas
GastroenterologyMen's HealthDermatologyOtherWomen's Health
Modalities
Small moleculeProbiotic (Live biotherapeutic product therapy)Medical deviceDietary supplement
Industry
Biotech
02

Drug pipeline

3 assets

lactobacillus casei DG

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

Kilometro Rosso Science and Technology Park – partnership for advanced microbiota/probiotics research[3]

Beyond the preview

Go deeper on SOFAR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOFAR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call